Adding aesthetic or elective procedures appeals to many ophthalmologists for a variety of reasons, one expert says.
This article was reviewed by Paulo E. Stanga, MD
When considering accomplishments recorded in the arena of gene therapy, the “firsts” are impressive.
This article was reviewed by Prof. Gus Gazzard, FRCOpthMA, MBBCHIR, MD
Findings from studies investigating the efficacy and safety of corneal collagen crosslinking (CXL) for keratoconus in paediatric-age patients and developmentally delayed adults and the consequences of leaving their ocular disease untreate
This article was reviewed by Donald Tran, MD
An abundance of evidence from randomised, controlled clinical trials supports the use of topical atropine to prevent myopia progression.
Segment 8. Emergence of minimally invasive glaucoma surgeries as an alternative for non-adherent patients.
Given the high incidence of age-related macular degeneration (AMD)—with some 10 to 11 million patients affected, 2 million of which have severe visual loss—the need for treatments to restore vision is clear.
Segment 7. Sahar Bedrood, MD, PhD, reveals how she addresses issues related to adherence with patients and the importance of lifestyle management.